Zentek Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Zentek hat ein Gesamteigenkapital von CA$18.6M und eine Gesamtverschuldung von CA$511.5K, was einen Verschuldungsgrad von 2.8% ergibt. Die Gesamtaktiva und Gesamtpassiva betragen CA$21.3M bzw. CA$2.7M.

Wichtige Informationen

2.8%

Verhältnis von Schulden zu Eigenkapital

CA$511.54k

Verschuldung

Zinsdeckungsgrad	n/a
Bargeld	CA$2.94m
Eigenkapital	CA$18.57m
Gesamtverbindlichkeiten	CA$2.69m
Gesamtvermögen	CA$21.26m

Jüngste Berichte zur Finanzlage

Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?

Jul 09

Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?

Aug 31

We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate

Mar 11

We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully

Nov 26

Recent updates

Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?

Jul 09

Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?

Aug 31

We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate

Mar 11

We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully

Nov 26

Analyse der Finanzlage

Kurzfristige Verbindlichkeiten: ZENDie kurzfristigen Aktiva des Unternehmens (CA$5.0M) übersteigen seine kurzfristigen Passiva (CA$2.4M).

Langfristige Verbindlichkeiten: ZENDie kurzfristigen Vermögenswerte des Unternehmens (CA$5.0M) übersteigen seine langfristigen Verbindlichkeiten (CA$250.6K).

Geschichte und Analyse des Verhältnisses von Schulden zu Eigenkapital

Verschuldungsgrad: ZEN über mehr Barmittel verfügt als seine Gesamtverschuldung.

Schulden abbauen: ZENDas Verhältnis von Schulden zu Eigenkapital ist in den letzten 5 Jahren von 0% auf 2.8% gestiegen.

Bilanz

Liquiditätsreserve-Analyse

Bei Unternehmen, die in der Vergangenheit im Durchschnitt Verluste gemacht haben, wird geprüft, ob sie über einen Liquiditätsvorlauf von mindestens einem Jahr verfügen.

Stabile Start- und Landebahn für Bargeld: ZEN hat auf der Grundlage seines derzeitigen freier Cashflows weniger als ein Jahr Liquiditätsspielraum.

Vorhersage Cash Runway: ZEN hat weniger als ein Jahr Liquiditätsreserven, wenn der freie Cashflow weiterhin mit den historischen Raten von 28% pro Jahr abnimmt

Zentek Balance Sheet Health

Finanzielle Gesundheit Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Berichte zur Finanzlage

Zentek Receives a Deficiency Letter from Nasdaq Stock Market LLC

Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?

Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?

We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate

We Think ZEN Graphene Solutions (CVE:ZEN) Needs To Drive Business Growth Carefully

Recent updates

New major risk - Financial position

New minor risk - Share price stability

Zentek Ltd. Provides Regulatory Update for ZenGUARD(TM) Enhanced Air Filters

Zentek Ltd. Provides Market Update on ZenGUARD Antimicrobial Surgical Masks

New minor risk - Shareholder dilution

Zentek Ltd. announced that it has received CAD 3.06995 million in funding

Director exercised options to buy CA$376k worth of stock.

Zentek Ltd. announced that it expects to receive CAD 3 million in funding

Full year 2024 earnings released: CA$0.12 loss per share (vs CA$0.14 loss in FY 2023)

CEO & Director exercised options to buy CA$308k worth of stock.

Zentek Ltd. Announces Board and Management Changes

Zentek Ltd. Provides ZenGUARD Business Update

New major risk - Financial position

Zentek Ltd.'s Subsidiary Triera Biosciences Ltd. Completes Testing of Its C19HBA Aptamer as Potential Therapeutic

Zentek Ltd. Completes Study Quantifying Energy and Emission Savings of ZenGUARD(TM)-Enhanced HVAC Filters

Zentek Ltd. Announces Board Changes

Zentek Ltd. Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant

Zentek Ltd. announced a financing transaction

Chief Science Officer exercised options to buy CA$61k worth of stock.

Zentek Ltd. Completes Return on Investment Analysis for Canadian Healthcare System

Zentek Ltd. Elects John Snisarenko as Director

Zentek Ltd Announces the Successful Results of A Recent Study Conducted by ParticleOne

Zentek Ltd. Announces the Results of Study Comparing the Viral Filtration Efficiency of Its Zenguard-Enhanced MERV 9 Filters with an Uncoated MERV 9 Filter

CEO & Director exercised options to buy CA$275k worth of stock.

First quarter 2024 earnings released: CA$0.03 loss per share (vs CA$0.051 loss in 1Q 2023)

Zentek Ltd., Annual General Meeting, Oct 05, 2023

Zentek and McMaster Announce Positive Results for Aptamer-Based Technology with Therapeutic Potential

Zentek Ltd. Announces Updates to Senior Management Team

COO & Director exercised options to buy CA$634k worth of stock.

Zentek Receives a Deficiency Letter from Nasdaq Stock Market LLC

Full year 2023 earnings released: CA$0.14 loss per share (vs CA$0.13 loss in FY 2022)

Zentek Ltd. Appoints Lisa Sim to the Board of Directors

Albany Graphite Corp. acquired Albany Graphite Project from Zentek Ltd. for approximately CAD 136 million.

Zentek Ltd. Introduces A Novel Corrosion Protection Technology: ZenARMOR

Zentek Ltd. Receives the Final Report for Phase 2 Testing of Zenguardtm for Use in Heating

Zentek Ltd. Receives the Final Report for Phase 2 Testing of Zenguardtm for Use in Heating

Zentek Ltd. Announces Appointment of Mitch Swergold as Director of Investor Relations

Zentek Ltd Announces Successful Phase 2 Results of HVAC Testing

Less than half of directors are independent

Zentek Ltd. Provides Update on Battery Technology Development

Zentek Provides Update on Icephobic Coating Technology

Zentek Ltd. Provides Update on HVAC Testing

Zentek Ltd., Annual General Meeting, Sep 29, 2022

Zentek Files Provisional Patent on the Use of ZenGUARD as an Anti-Inflammatory Agent

Does Zentek (CVE:ZEN) Have A Healthy Balance Sheet?

Zentek Ltd. Appoints Ilse Treurnicht to Its Board of Directors

Zentek Ltd. Provides Update on ZenGUARDTM Patent Status

Zentek Ltd. Announces Chief Financial Officer Changes

Less than half of directors are independent

Zentek Ltd. Announces Start of Phase Two Testing of Zenguardtm -Coated Filters

Zentek Ltd. Announces Filing of Provisional Patent for Fire-Retardant Additive

Zentek Ltd. Appoints Ravi Kaza to Its Advisory Board

Zentek Ltd. Announces Development of Graphene-Wrapped Silicon Anodes

Zentek Ltd. announced that it has received CAD 10.009022 million in funding

Zentek Ltd. announced that it expects to receive CAD 10.009022 million in funding

CEO & Director recently bought CA$149k worth of stock

Zen Graphene Solutions and Trebor Rx Announce Health Canada Approval for ZENGuardTM Mask

CEO & Director exercised options to buy CA$1.7m worth of stock.

President exercised options and sold CA$106k worth of stock

Is ZEN Graphene Solutions (CVE:ZEN) In A Good Position To Deliver On Growth Plans?

CEO & Director recently bought CA$146k worth of stock

ZEN Graphene Solutions Ltd. Develops Stable Diesel Fuel Additive

ZEN Graphene Solutions Ltd. announced that it has received CAD 4.337998 million in funding

ZEN Graphene Solutions Ltd. announced that it expects to receive CAD 2 million in funding

ZEN Graphene Solutions Ltd. Announces Successful Testing of its Graphene Compound Against Antimicrobial-Resistant Bacteria

We're Keeping An Eye On ZEN Graphene Solutions' (CVE:ZEN) Cash Burn Rate

ZEN Graphene Solutions and Trebor Rx Corp. Announce Successful Health Canada Testing Requirements of Surgical Masks

Zen Graphene Solutions Announces Initial Phase 2 Cytotoxicity Results for Its Graphene-Based Compound

ZEN Graphene Solutions Ltd. Announces Management Changes

New 90-day high: CA$3.75